Abstract
Background: Momordica charantia, Gymnema sylvestre, and Piper betle are developing as optional therapy in type 2 diabetes. Animal studies are helping to reveal its anti-diabetic properties. However, clinical studies in human subjects are few. Aims and Objectives: To know the effect of M. charantia on fasting glycemic control in rabbits. Materials and Methods: Blood samples from overnight fasting diabetic rabbits were collected. The drug and vehicle at the indicated dosages were then administered orally to the respective groups using a pediatric nasogastric tube followed by 2 mL of distilled water through the same tube. Subsequent blood samples were taken 2, 4, and 8 h after drug administration, and plasma glucose was estimated for each sample. Results: The standard drug, glyburide, significantly reduces hyperglycemia over a period of 2, 4, and 8 h, with maximum effect achieved after 4 h. Therefore, the choice of a diabetic rabbit animal model is authentic and appropriate. Conclusion: These three herbal extracts were more or less equivalent in reducing fasting blood glucose compared to glyburide in a rabbit model.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: National Journal of Physiology, Pharmacy and Pharmacology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.